
Visiomed Group SA
PAR:ALVMG

Visiomed Group SA?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.1646
0.202
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Visiomed Group SA hold over its rivals?
What risks and challenges
does Visiomed Group SA face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Visiomed Group SA.
Provide an overview of the primary business activities
of Visiomed Group SA.
What unique competitive advantages
does Visiomed Group SA hold over its rivals?
What risks and challenges
does Visiomed Group SA face in the near future?
Has there been any significant insider trading activity
in Visiomed Group SA recently?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Visiomed Group SA.
Provide P/S
for Visiomed Group SA.
Provide P/E
for Visiomed Group SA.
Provide P/OCF
for Visiomed Group SA.
Provide P/FCFE
for Visiomed Group SA.
Provide P/B
for Visiomed Group SA.
Provide EV/S
for Visiomed Group SA.
Provide EV/GP
for Visiomed Group SA.
Provide EV/EBITDA
for Visiomed Group SA.
Provide EV/EBIT
for Visiomed Group SA.
Provide EV/OCF
for Visiomed Group SA.
Provide EV/FCFF
for Visiomed Group SA.
Provide EV/IC
for Visiomed Group SA.
Show me price targets
for Visiomed Group SA made by professional analysts.
What are the Revenue projections
for Visiomed Group SA?
How accurate were the past Revenue estimates
for Visiomed Group SA?
What are the Net Income projections
for Visiomed Group SA?
How accurate were the past Net Income estimates
for Visiomed Group SA?
What are the EPS projections
for Visiomed Group SA?
How accurate were the past EPS estimates
for Visiomed Group SA?
What are the EBIT projections
for Visiomed Group SA?
How accurate were the past EBIT estimates
for Visiomed Group SA?
Compare the revenue forecasts
for Visiomed Group SA with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Visiomed Group SA and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Visiomed Group SA against its competitors.
Analyze the profit margins
(gross, operating, and net) of Visiomed Group SA compared to its peers.
Compare the P/E ratios
of Visiomed Group SA against its peers.
Discuss the investment returns and shareholder value creation
comparing Visiomed Group SA with its peers.
Analyze the financial leverage
of Visiomed Group SA compared to its main competitors.
Show all profitability ratios
for Visiomed Group SA.
Provide ROE
for Visiomed Group SA.
Provide ROA
for Visiomed Group SA.
Provide ROIC
for Visiomed Group SA.
Provide ROCE
for Visiomed Group SA.
Provide Gross Margin
for Visiomed Group SA.
Provide Operating Margin
for Visiomed Group SA.
Provide Net Margin
for Visiomed Group SA.
Provide FCF Margin
for Visiomed Group SA.
Show all solvency ratios
for Visiomed Group SA.
Provide D/E Ratio
for Visiomed Group SA.
Provide D/A Ratio
for Visiomed Group SA.
Provide Interest Coverage Ratio
for Visiomed Group SA.
Provide Altman Z-Score Ratio
for Visiomed Group SA.
Provide Quick Ratio
for Visiomed Group SA.
Provide Current Ratio
for Visiomed Group SA.
Provide Cash Ratio
for Visiomed Group SA.
What is the historical Revenue growth
over the last 5 years for Visiomed Group SA?
What is the historical Net Income growth
over the last 5 years for Visiomed Group SA?
What is the current Free Cash Flow
of Visiomed Group SA?
Discuss the annual earnings per share (EPS)
trend over the past five years for Visiomed Group SA.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
FR |
![]() |
Visiomed Group SA
PAR:ALVMG
|
50.8m EUR | 16.6 | |
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
228.6B USD | 22 |
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
198B USD | 64.5 |
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
154.6B USD | 35.8 |
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
145.3B USD | 25.2 |
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
104.1B USD | 12.6 |
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
52.8B EUR | 14.2 |
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
49.6B USD | 13.1 |
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
45.1B USD | 24.7 |
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
41.5B USD | 32.9 |
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
279.5B CNY | 22 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
FR |
![]() |
Visiomed Group SA
PAR:ALVMG
|
Average EV/EBITDA:
25.8
16.6
|
N/A | N/A | |
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
22
|
13%
|
1.7 |
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
64.5
|
24%
|
2.7 |
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
35.8
|
21%
|
1.7 |
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
25.2
|
12%
|
2.1 |
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
12.6
|
5%
|
2.5 |
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
14.2
|
14%
|
1 |
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
13.1
|
11%
|
1.2 |
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
24.7
|
12%
|
2.1 |
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
32.9
|
12%
|
2.7 |
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
22
|
16%
|
1.4 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.